Toward understanding toxicity over time (ToxT) in myeloma cooperative group trials: Feasibility of a novel longitudinal adverse event analysis in ECOG-ACRIN E1A06

Authors :: Susanna Jacobus
Timothy E. O'Brien
Asher Chanan-Khan
Paul J. Novotny
David L. Grinblatt
A. Keith Stewart
S. Vincent Rajkumar
Madhu V. Midathada
Gita Thanarajasingam
Rafael Fonseca
Natalie S. Callander
Rahma Warsame
Avina A. Singh
Amylou C. Dueck
Donald MacFarlene
Source :: Journal of Clinical Oncology. 36:6580-6580
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 6580Background: Given the many chronically administered agents now used in cancer therapy, there is pressing need to elucidate safety and tolerability of therapy over time. Conventional methods of ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Tolerability
business.industry
Internal medicine
Toxicity
Cancer therapy
Cooperative group
Medicine
Adverse effect
business

Full Text Access

Tools